Publications by authors named "Borja Enrique Sanz-Cuesta"
Article Synopsis
- The study aimed to assess how anticoagulation affects the severity and outcomes of cardioembolic stroke (CS) and the response to intravenous thrombolysis (IVT), analyzing data from patients treated at a Stroke Center from 2010 to 2013.
- The sample consisted of 475 patients, with a majority classified based on their pre-stroke anticoagulant treatment and INR levels, revealing that higher INR levels (≥2) correlated with milder stroke severity and better outcomes after three months.
- Additionally, while therapeutic anticoagulation levels improved CS severity and outcomes, the study found no link between anticoagulation and response to IVT.
Background: Rat adipose tissue-derived-mesenchymal stem cells (rAD-MSCs) have proven to be safe in experimental animal models of stroke. However, in order to use human AD-MSCs (hAD-MSCs) as a treatment for stroke patients, a proof of concept is needed. We analyzed whether the xenogeneic hAD-MSCs were as safe and effective as allogeneic rAD-MSCs in permanent Middle Cerebral Artery Occlusion (pMCAO) in rats.
View Article and Find Full Text PDFIntroduction: It is unknown whether monitors that include atrial fibrillation recognition software (AF-RS) increase the rate of early atrial fibrillation (AF) detection in acute stroke. We aimed to evaluate the AF detection rate of an AF-RS monitor and compare it with standard monitoring.
Methods: This was a retrospective, single-centre observational study conducted on consecutive patients with acute transient ischaemic attack or brain infarction attended in a stroke unit (SU) with six beds.
Objective: To examine the effects of pretreatment with statins at high doses (40 mg of rosuvastatin or 80 mg of any other statin) and low to moderate doses (<40 mg of rosuvastatin or <80 mg of any other statin) on ischemic stroke (IS) severity in clinical practice.
Methods: Observational study of IS admissions to our stroke unit over a 3-year period (2008-2010). Mild stroke severity was defined as NIH Stroke Scale score ≤5 on admission.